GFAP and myeloid sarcoma: However, some previously suggested MS markers (including C1QA, CCL2, CXCL1, GFAP, HGF, and OPN) had non-significant log2 fold change (FC; −0.25–0.34) when comparing pwMS to HC (see Supplementary Fig. 4).